AKT1 and neoplasm: Impaired systemic insulin signalling by the growing tumour accounted for part of these impairments, i.e. reduced left ventricular (LV) function, reduced phosphorylation of AKT, enhanced UPS and autophagy, as well as reduced cardiac glucose uptake [2].